{
    "RADCURE-3409": {
        "question": "Age: 57.2, Sex: Male, ECOG PS: ECOG 0, Smoking PY: 40, Smoking Status: Current, Ds Site: Hypopharynx, Subsite: Pyriform Sinus, T: T2, N: N2b, M : M0, Stage: IVA, Path: Squamous Cell Carcinoma, HPV: none, Tx Modality: ChemoRT, Chemo? : Yes, Dose: 70.0, Fx: 35, Local: none, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-negative cases involving the hypopharynx. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "Step-by-step analysis as a radiation oncologist:\n\n1. The CT scan is of the head and neck region, with two bounding boxes provided:\n   - Box 1: [264, 222, 57, 264, 297, 152]\n   - Box 2: [254, 165, 111, 254, 207, 127]\n\n2. These coordinates are normalized and define volumetric regions within the scan. The first box appears to cover a larger volume, possibly including parts of the oropharynx or hypopharynx, and adjacent soft tissues or lymph nodes.\n\n3. The second box is smaller and more localized, possibly representing a lymph node or a smaller lesion within the neck.\n\n4. From a radiation oncology perspective, these ROIs could represent:\n   - Primary tumor site (e.g., oropharyngeal or hypopharyngeal squamous cell carcinoma)\n   - Involved lymph nodes (nodal metastases)\n\n5. Visible anatomical structures likely include:\n   - Pharyngeal airway\n   - Cervical vertebrae (posteriorly)\n   - Soft tissues of the neck including muscles and lymph nodes\n\n6. Patterns or abnormalities:\n   - The presence of masked ROIs suggests areas of interest, likely tumor or involved nodes.\n   - The size and location of these ROIs are critical for radiation treatment planning to ensure adequate dose coverage while sparing normal tissues.\n\n7. Survival probability considerations:\n   - Tumor location and nodal involvement are key prognostic factors.\n   - HPV status (not provided here) would influence prognosis significantly.\n   - Larger or multiple nodal involvements generally worsen prognosis.\n   - Radiation dose and fractionation, along with concurrent chemotherapy, impact outcomes.\n\nSince no clinical details such as tumor stage, HPV status, or treatment are provided, and only imaging ROIs are given, a definitive survival prediction cannot be made solely on this data.\n\nFinal answer:\nAnswer:Alive",
        "initial_assessment_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-radiation oncologist": "Answer:no",
        "Round 2-Turn 1-ask_gap_review_assessment-radiation oncologist": "---\nAnswer: no\nReason: sufficient expertise within scope\n---",
        "Round 2-role-comment": "radiation oncologist:alive",
        "Round 2-num_agents": 1,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}